中文 | English
Return
Total: 1 , 1/1
Show Home Prev Next End page: GO
MeSH:(Lymphoma, Non-Hodgkin/complications/*drug therapy/metabolism)

1.The Prophylactic Use of Lamivudine Can Maintain Dose-Intensity of Adriamycin in Hepatitis-B Surface Antigen (HBs Ag)-positive Patients with Non-Hodgkin's Lymphoma Who Receive Cytotoxic Chemotherapy.

Gyeong Won LEE ; Min Hee RYU ; Jae Lyun LEE ; Sukjoong OH ; Eunkyoung KIM ; Jae Hwan LEE ; Seung Bae KIM ; Sang We KIM ; Cheolwon SUH ; Kyoo Hyung LEE ; Woo Kun KIM ; Jung Shin LEE ; Yoon Koo KANG

Journal of Korean Medical Science 2003;18(6):849-854

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1 , 1/1 Show Home Prev Next End page: GO